2006 Principal Investigator
A Phase 3, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Study
Assessing the Safety and Efficacy of XXX Microgranules Oral Suspension in Infants with Symptomatic Gastroesophageal Reflux Disease.
2007 Principal Investigator
A Multicenter, Randomized, Double-Blind Study of the Clinical Outcomes, Safety and Tolerability of Multiple Doses of XXX ...